| 000 | 01301 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517075030.0 | ||
| 264 | 0 | _c20161213 | |
| 008 | 201612s 0 0 ger d | ||
| 022 | _a1435-1250 | ||
| 024 | 7 |
_a10.1007/s00393-016-0044-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchmalzing, M | |
| 245 | 0 | 0 |
_a[Gynecological cancers in patients with inflammatory rheumatic diseases]. _h[electronic resource] |
| 260 |
_bZeitschrift fur Rheumatologie _cFeb 2016 |
||
| 300 |
_a63-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenital Neoplasms, Female _xchemically induced |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xcomplications |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKrockenberger, M | |
| 700 | 1 | _aHonig, A | |
| 700 | 1 | _aTony, H-P | |
| 773 | 0 |
_tZeitschrift fur Rheumatologie _gvol. 75 _gno. 1 _gp. 63-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00393-016-0044-z _zAvailable from publisher's website |
| 999 |
_c25671927 _d25671927 |
||